Stockreport
ISRG Q1 2026 Earnings Transcript [Globe and Mail, The (Toronto, Canada)]
Last intuitive surgical, inc. earnings: 4/16 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations: phx.corporate-ir.net/phoenix.zhtml?c=122359&p=irol-irhome
Chief Financial Officer — Jamie Samath Chief Medical Officer — Jamie Wong Senior Vice President, Strategy & Investor Relations — Daniel Connally TAKEAWAYS Total Procedures -- Increased 17% to 890,000, including 16% growth in da Vinci and 39% growth in Ion procedures. da Vinci Procedures (U.S.) -- Rose 14%, supported by 31% growth in after-hours procedures and a 4% increase in U.S. utilization, with da Vinci 5 utilization about 11% higher than Xi. da Vinci Procedures (Outside U.S.) -- Grew 19%, now representing 38% of total da Vinci volume, led by general surgery and gynecology; Asia growth lagged, with ongoing challenges in China and Japan. Ion Procedures -- Expanded 39% to 43,000 procedures, including clinical adoption reinforced by recent Mayo Clinic data showing a diagnostic yield of 79% and sensitivity of 85% for malignancy. Single Port (SP) Platform Procedures -- Increased 68%, driven by adoption in Korea, the U.S., and early-stage growth in Europe, Japan, and Ta
[Read more]
| IMPACT SNAPSHOT | EVENT TIME: | ISRG | ||||
|---|---|---|---|---|---|---|
|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| LAST PRICE | ||
| VWAP | ||
|
High:
|
MAX UP |
High:
|
|
Low:
|
MAX DOWN |
Low:
|
|
%
|
POST NEWS RANGE |
%
|
|
|
PRICE CHANGE |
|
|
|
PRICE CHANGE PERCENTAGE |
|
|
|
S&P 500 (SPX) |
|
|
%
|
VOLUME RATIO |
%
|
| VOLUME (SHARES) | ||
| TICKS | ||
|
|
AVG SHARES PER TRADE |
|
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Be the first to know
Opt in for alerts from News Quantifed
Opt-in for
ISRG alerts
ISRG alerts
from News Quantified
Movers & Shakers
The biggest gainers and losers and WHY it moved
ISRG alerts
High impacting Intuitive Surgical, Inc. news events
Weekly update
A roundup of the hottest topics
ISRG
NEWS
NEWS
- ISRG Q3 2024 Earnings Transcript [Globe and Mail, The (Toronto, Canada)][Globe and Mail, The]
- Intuitive Surgical (ISRG) had its price target raised by Robert W. Baird from $575.00 to $610.00. They now have an "outperform" rating on the stock.[MarketBeat]
- Intuitive Surgical (ISRG) had its price target raised by The Goldman Sachs Group, Inc. from $609.00 to $621.00. They now have a "buy" rating on the stock.[MarketBeat]
- Intuitive Surgical (ISRG) had its price target lowered by Jefferies Financial Group Inc. from $560.00 to $515.00. They now have a "hold" rating on the stock.[MarketBeat]
- Intuitive Surgical (ISRG) had its price target lowered by Raymond James Financial, Inc. from $615.00 to $577.00. They now have an "outperform" rating on the stock.[MarketBeat]
- More
ISRG
SEC Filings
SEC Filings
- 4/21/26 - Form 8-K
- 3/27/26 - Form SCHEDULE
- 3/13/26 - Form DEFA14A
- ISRG's page on the SEC website
- More